Market - Page 91 of 134 - Express Pharma

DoP extends excise duty exemption on formulations under DPCO 2013

World’s pharma development manufacturing base moving to India: IBEF

Ranbaxy allocates site for greenfield manufacturing facility in Malaysia

Biocon introduces novel biologic, ALZUMAb for psoriasis in India

West-Coast Pharmaceutical Works to foray into nutraceutical segment

Glenmark gets final ANDA approval for acamprosate

Venus Pharma gets marketing authorisation approval from France

DPCO’13 impacts July growth

Lex Witness to organise 2nd Annual Pharma Legal & Compliance Summit 2013

IPA organises clinical research conference